Latest Round Of TPP Talks End Without Resolving Drug Patent Extension Issues
This article was originally published in PharmAsia News
Executive Summary
The issue of drug patent protection was left unsettled as the latest round of Trans-Pacific Partnership Agreement negotiations ended with Asia member nations such as the host, Malaysia, raised cost issues.